The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

In a deal valued at up to $1 billion, Roche has licensed rights to a DLL3-directed antibody-drug conjugate (ADC) from China's ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase ...

Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo. 2. In ...

Nature: Experimental drug may help prevent cancer recurrence After resuming work, the backlog of patients in many departments has increased explosively! Imfinzi alone and in combination with tremelimu ...

INR:6786. skrill 1 tap bet365 CROMSOURCE continues its US growth with new office in Research Triangle Park AstraZeneca's Imfinzi and two combination therapies ...

INR:7533. test match ka live score New bladder cancer treatment Imfinzi + Lynparza achieves 50% pathological complete response rate 『Pharmaceutical Hea ...

INR:3681. new casino games free no deposit Amplifying nerve signals in the arm, scientists use the brain to control prosthetic limbs more precise ...

INR:6144. south africa vs new zealand cricket live streaming free Hengrui Medicine's SHR-1707 approved for clinical trial ...

INR:3777. blind cricket 『Pharmaceutical Headlines』 Liaoning Province cancels village-level vaccination sites, Amgen lays off another 172 employees Another 21 li ...

INR:9367. birthday of virat kohli Huazhong Pharmaceutical's "Ambroxol Hydrochloride Injection" was approved as the second company to pass the consistency ...